ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm
Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.
Stay updated with breaking news from Asco Gi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.
Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC.
Efrat Dotan, MD, discusses the use of geriatric function assessments in elderly patients with gastroesophageal cancer.
Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer.
Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.